These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6523431)

  • 41. A collaborative study to establish the 3rd International Standard for tissue plasminogen activator.
    Sands D; Whitton CM; Merton RE; Longstaff C
    Thromb Haemost; 2002 Aug; 88(2):294-7. PubMed ID: 12195703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An International Standard for specifying the minimum potency of anti-D blood-grouping reagents: evaluation of a candidate preparation in an international collaborative study.
    Thorpe SJ; Fox B; Heath AB; Scott M; de Haas M; Kochman S; Padilla A
    Vox Sang; 2006 Feb; 90(2):131-9. PubMed ID: 16430672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Collaborative study for the establishment of the second international standard for amphotericin B.
    Rautmann G; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Apr; 2010(1):1-13. PubMed ID: 20223186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Collaborative study of Japanese Pharmacopoeia Heparin Sodium Reference Standard (Control 871)].
    Yomota C; Hasegawa R; Komuro T; Okada S; Kimura T
    Eisei Shikenjo Hokoku; 1989; (107):148-51. PubMed ID: 2636920
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An international collaborative study to establish the WHO 1st international standard for alpha-1-antitrypsin.
    Thelwell C; Marszal E; Rigsby P; Longstaff C
    Vox Sang; 2011 Jul; 101(1):83-9. PubMed ID: 21668863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A collaborative study of a proposed international standard for tissue plasminogen activator (t-PA).
    Gaffney PJ; Curtis AD
    Thromb Haemost; 1985 Feb; 53(1):134-6. PubMed ID: 4039472
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An international standard for low molecular weight heparin.
    Barrowcliffe TW; Curtis AD; Johnson EA; Thomas DP
    Thromb Haemost; 1988 Aug; 60(1):1-7. PubMed ID: 2847351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. International standards for minimum potency of anti-A and anti-B blood grouping reagents: evaluation of candidate preparations in an international collaborative study.
    Thorpe SJ; Fox B; Heath AB; Scott M; de Haas M; Kochman S; Padilla A
    Vox Sang; 2006 Nov; 91(4):336-44. PubMed ID: 17105610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Collaborative study for the recalibration of Ph. Eur. Heparin sodium BRP batch 3 for chromogenic potency assays.
    Daas A; Rautmann G; Terao E
    Pharmeur Bio Sci Notes; 2014; 2014():103-17. PubMed ID: 25655247
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An international collaborative study to replace the 1st international standard for prekallikrein activator.
    Longstaff C; Behr-Gross ME; Daas A; Lackner F
    Vox Sang; 2005 Feb; 88(2):143-51. PubMed ID: 15720613
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Collaborative study for the establishment of the 3rd international standard for neomycin.
    Rautmann G; Daas A; Buchheit KH
    Pharmeur Bio Sci Notes; 2013; 2013():93-111. PubMed ID: 24447724
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Collaborative study for the establishment of replacement batches of heparin low- molecular-mass for assay biological reference preparations.
    Terao E; Daas A; Rautmann G; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):30-6. PubMed ID: 21144487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A collaborative study of proposed European Pharmacopoeia reference preparations of low molecular mass heparin.
    Gray E; Heath AB; Mulloy B; Spieser JM; Barrowcliffe TW
    Thromb Haemost; 1995 Sep; 74(3):893-9. PubMed ID: 8571317
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the neutralizing effects of protamine on unfractionated and low molecular weight heparin (Fragmin) at the site of activation of the coagulation system in man.
    Wolzt M; Weltermann A; Nieszpaur-Los M; Schneider B; Fassolt A; Lechner K; Eichler HG; Kyrle PA
    Thromb Haemost; 1995 Mar; 73(3):439-43. PubMed ID: 7667826
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 58. International collaborative study by in vitro bioassays and immunoassays of the First International Standard for Inhibin, Human Recombinant.
    Rose MP; Gaines Das RE
    Biologicals; 1996 Mar; 24(1):1-18. PubMed ID: 8733597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The International and "NIH" units for thrombin--how do they compare?
    Gaffney PJ; Edgell TA
    Thromb Haemost; 1995 Sep; 74(3):900-3. PubMed ID: 8571318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A collaborative study to establish a Korea national biological standard for antithrombin concentrate.
    Kang HN; Han Lee S; Nam Kim S; Man Hong C; Ho Lee S; Hwa Hong S
    Thromb Res; 2006; 117(5):591-6. PubMed ID: 15992867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.